pfizer glp-1 drug Danuglipron: Pfizer's receptor agonist weight loss pill Safety worries spur Pfizer to

Some Medicare patients will be able to access GLP-1 medication for weight loss for the first time starting July 1, paying a $50 monthly copay through a new program designed to make the drugs more...

The term natural is often misunderstood

Background Glucagon-like peptide-1 (GLP-1) induces diuresis and natriuresis

The World Obesity Atlas 2024 reports over 1.5 billion projected cases by 2035, highlighting its growing threat among pediatric and adult populations globally

Shima Hadidchi, MD, in Apple Valley and Victorville, CA

Researchers are examining whether drugs currently approved to treat obesity and type 2 diabetes could be useful for a wider range of health challenges.